US Stock MarketDetailed Quotes

Biogen (BIIB)

Watchlist
  • 199.360
  • +1.410+0.71%
Close May 12 16:00 ET
  • 199.540
  • +0.180+0.09%
Post 20:01 ET
29.43BMarket Cap21.44P/E (TTM)

Biogen (BIIB) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
TYSABRI441.5M17.82%
Revenue from anti-CD20 therapeutic programs419.1M16.91%
SPINRAZA374M15.09%
Other271.8M10.97%
Contract manufacturing, royalty and other revenue246.9M9.96%
VUMERITY179M7.22%
AVONEX163.2M6.59%
SKYCLARYS150.7M6.08%
BENEPALI122.1M4.93%
TECFIDERA109.5M4.42%
View all

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
U.S.5.74B58.01%
Europe1.88B19.05%
Germany853M8.62%
Asia726.5M7.35%
Other511.2M5.17%
Alzheimer's collaboration revenue177.7M1.80%
View all
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More